ClinicalTrials.Veeva

Menu

Changes in Cardiovascular Hemodynamics During Peritoneal Dialysis

University of Aarhus logo

University of Aarhus

Status

Terminated

Conditions

Peritoneal Dialysis

Treatments

Drug: Icodextrin (dialysate)
Drug: Physioneal (dialysate) 1.36% and 2.27%

Study type

Interventional

Funder types

Other

Identifiers

NCT00119990
AA20050009

Details and patient eligibility

About

During peritoneal dialysis, water is removed from the body. This sometimes occurs at rates of up to 500 ml/h. During shifts with dialysate with high glucose content, an increase in blood pressure has been described. The effect upon central hemodynamics is unknown. The researchers are investigating the effects of low and high glucose dialysate and icodextrin on cardiac output, stroke volume, pulse rate and blood pressure. The researchers have hypothesized that the effects seen are induced by vasopressin.

Enrollment

15 estimated patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Peritoneal dialysis patients

Exclusion criteria

  • Insulin dependent diabetes mellitus
  • AV-fistula, cardial arrhythmia persistence, or severe cardiac and lung disease
  • Recent infectious disease
  • Severe psychiatric disease
  • Hypersensitivity to icodextrin

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems